IL214257A - Preparation containing polypeptides for use in preventing and treating allergy to herbal dust by tolerating - Google Patents

Preparation containing polypeptides for use in preventing and treating allergy to herbal dust by tolerating

Info

Publication number
IL214257A
IL214257A IL214257A IL21425711A IL214257A IL 214257 A IL214257 A IL 214257A IL 214257 A IL214257 A IL 214257A IL 21425711 A IL21425711 A IL 21425711A IL 214257 A IL214257 A IL 214257A
Authority
IL
Israel
Prior art keywords
tolerisation
polypeptides
preventing
composition
grass pollen
Prior art date
Application number
IL214257A
Other languages
English (en)
Hebrew (he)
Other versions
IL214257A0 (en
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0901928A external-priority patent/GB0901928D0/en
Priority claimed from GBGB0901927.4A external-priority patent/GB0901927D0/en
Priority claimed from GB0912578A external-priority patent/GB0912578D0/en
Priority claimed from PCT/GB2009/001995 external-priority patent/WO2010018384A1/en
Priority claimed from GB0917871A external-priority patent/GB0917871D0/en
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of IL214257A0 publication Critical patent/IL214257A0/en
Publication of IL214257A publication Critical patent/IL214257A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0008Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56977HLA or MHC typing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
IL214257A 2009-02-05 2011-07-24 Preparation containing polypeptides for use in preventing and treating allergy to herbal dust by tolerating IL214257A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0901928A GB0901928D0 (en) 2009-02-05 2009-02-05 Peptides for vaccine
GBGB0901927.4A GB0901927D0 (en) 2009-02-05 2009-02-05 Peptide for IL10 production
GB0912578A GB0912578D0 (en) 2009-07-20 2009-07-20 Peptide for IL-10 production
PCT/GB2009/001995 WO2010018384A1 (en) 2008-08-15 2009-08-14 T-cell antigen peptide from allergen for stimulation of il-10 production
GB0917871A GB0917871D0 (en) 2009-10-12 2009-10-12 Peptides for vaccine
PCT/GB2010/000198 WO2010089554A1 (en) 2009-02-05 2010-02-05 Peptides for vaccine

Publications (2)

Publication Number Publication Date
IL214257A0 IL214257A0 (en) 2011-09-27
IL214257A true IL214257A (en) 2016-06-30

Family

ID=42082585

Family Applications (1)

Application Number Title Priority Date Filing Date
IL214257A IL214257A (en) 2009-02-05 2011-07-24 Preparation containing polypeptides for use in preventing and treating allergy to herbal dust by tolerating

Country Status (23)

Country Link
US (2) US8753644B2 (cg-RX-API-DMAC7.html)
EP (2) EP2393830B8 (cg-RX-API-DMAC7.html)
JP (2) JP5746053B2 (cg-RX-API-DMAC7.html)
KR (1) KR20110111307A (cg-RX-API-DMAC7.html)
CN (2) CN102307893B (cg-RX-API-DMAC7.html)
AU (1) AU2010212193B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1008802A2 (cg-RX-API-DMAC7.html)
CA (1) CA2751500A1 (cg-RX-API-DMAC7.html)
DK (1) DK2393830T3 (cg-RX-API-DMAC7.html)
EA (1) EA020792B1 (cg-RX-API-DMAC7.html)
ES (1) ES2532759T3 (cg-RX-API-DMAC7.html)
GB (1) GB2469894B (cg-RX-API-DMAC7.html)
HK (1) HK1212358A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20150317T1 (cg-RX-API-DMAC7.html)
IL (1) IL214257A (cg-RX-API-DMAC7.html)
MX (1) MX2011008179A (cg-RX-API-DMAC7.html)
NZ (1) NZ594268A (cg-RX-API-DMAC7.html)
PL (1) PL2393830T3 (cg-RX-API-DMAC7.html)
PT (1) PT2393830E (cg-RX-API-DMAC7.html)
SG (1) SG173523A1 (cg-RX-API-DMAC7.html)
SI (1) SI2393830T1 (cg-RX-API-DMAC7.html)
WO (1) WO2010089554A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201105436B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1008802A2 (pt) * 2009-02-05 2016-03-08 Circassia Ltd composição, vetor e formulação farmacêutica para o uso na prevenção ou tratamento de alergia a pólen de grama por tolerização, produto, e, método in vitro para determinar se as células t reconhecem uma composição
CN118078979A (zh) 2011-04-29 2024-05-28 西莱克塔生物科技公司 用于降低针对治疗性蛋白的免疫应答的致耐受性合成纳米载体
US10434088B2 (en) 2013-05-03 2019-10-08 Selecta Biosciences, Inc. Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose
WO2016037165A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
US11013781B2 (en) 2015-07-01 2021-05-25 Alk-Abelló As Peptide combinations and uses thereof for treating grass allergy
CA3055936A1 (en) 2017-03-11 2018-09-20 Selecta Biosciences, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
CN108802216B (zh) * 2018-05-23 2021-04-16 山东出入境检验检疫局检验检疫技术中心 一种使用区域敏感性蛋白组和/或多肽组鉴别刺参产地的方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340729C (en) 1988-03-23 1999-09-07 Mohan Bir Singh Ryegrass pollen allergen
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
CA2089735C (en) 1990-08-17 2008-03-18 Mohan Bir Singh Ryegrass pollen allergen
WO1992016554A1 (en) 1991-03-14 1992-10-01 The University Of Melbourne Protein allergens of the species cynodon dactylon
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
ATE260342T1 (de) 1991-08-16 2004-03-15 Univ Melbourne Weidelgraspollen-allergen
WO1993010236A1 (en) 1991-11-15 1993-05-27 The University Of Melbourne Protein allergens of the species cynodon dactylon
US6441157B1 (en) 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
JP3868480B2 (ja) 1992-08-14 2007-01-17 ザ・ユニバーシテイ・オブ・メルボルン ライグラス花粉アレルゲンのt細胞エピトープ
US6214358B1 (en) 1992-10-30 2001-04-10 Immulogic Pharamaceutical Corp. Protein allergens of the species Cynodon dactylon
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
NZ263913A (en) * 1993-03-12 1997-10-24 Immulogic Pharma Corp Lol pi protein allergen from ryegrass and related peptides coding sequences, vectors, protein production and use
NZ271818A (en) * 1993-08-13 1997-11-24 Immulogic Pharma Corp T cell epitopes of ryegrass pollen antigen
US5820862A (en) 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
GB9412714D0 (en) 1994-06-24 1994-08-17 Lewin Ian V T cill epitopes
AU3338195A (en) * 1994-07-26 1996-02-22 University Of Manitoba Allergen peptides
US7112333B1 (en) * 1994-08-05 2006-09-26 Heska Corporation T cell epitopes of ryegrass pollen allergen
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
AT402505B (de) 1995-08-02 1997-06-25 Biomay Prod & Handel Rekombinantes 60 kda pflanzliches panallergen (kofaktor-unabhängige phosphoglyceratmutase; e.c. 5.4.2.1.)
EP1044019A1 (en) 1998-01-09 2000-10-18 Circassia Limited Methods and compositions for desensitisation
DE19823097A1 (de) * 1998-05-22 1999-11-25 Max Planck Gesellschaft Mittel gegen saisonale Typ-I-Allergien und bakterielle Infektionen
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
DE60229979D1 (cg-RX-API-DMAC7.html) 2001-12-05 2009-01-02 Circassia Ltd
AUPS148202A0 (en) 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
AU2003228133A1 (en) 2002-04-22 2003-11-03 Umc Utrecht Holding B.V. Reduction of unwanted immune reactions
GB0210741D0 (en) 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
GB0308988D0 (en) 2003-04-17 2003-05-28 Univ Singapore Molecule
DE102004035337A1 (de) * 2004-07-21 2006-03-16 Merck Patent Gmbh Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität
WO2006075253A2 (en) 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
EP1899367A4 (en) 2005-06-10 2009-06-24 Univ Singapore Mutant allergen(s)
DE202005009990U1 (de) * 2005-06-25 2006-11-02 Hengst Gmbh & Co.Kg Vorrichtung zum Abscheiden von Ölteilchen aus dem Kurbelgehäuseentlüftungsgas einer Brennkraftmaschine
US20070092532A1 (en) 2005-10-25 2007-04-26 Board Of Trustees Operating Michigan State University Arthritis vaccines and methods
US8748126B2 (en) 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
ES2425486T3 (es) 2007-05-09 2013-10-15 Circassia Limited Análisis de pronóstico para determinar la respuesta de células T a antígenos HLA y uso del mismo en el campo del trasplante de tejidos
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
WO2009022155A2 (en) * 2007-08-15 2009-02-19 Circassia Limited Peptide with reduced dimer formation
EP2042193A1 (en) 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
US8821887B2 (en) 2008-08-15 2014-09-02 Circassia Limited T-cell antigen peptide from allergen for stimulation of IL-10 production
BRPI1008802A2 (pt) * 2009-02-05 2016-03-08 Circassia Ltd composição, vetor e formulação farmacêutica para o uso na prevenção ou tratamento de alergia a pólen de grama por tolerização, produto, e, método in vitro para determinar se as células t reconhecem uma composição

Also Published As

Publication number Publication date
CN102307893B (zh) 2014-03-26
GB201001954D0 (en) 2010-03-24
JP2015180646A (ja) 2015-10-15
GB2469894B (en) 2011-09-07
US20120148612A1 (en) 2012-06-14
CA2751500A1 (en) 2010-08-12
PL2393830T3 (pl) 2015-07-31
BRPI1008802A2 (pt) 2016-03-08
GB2469894A (en) 2010-11-03
WO2010089554A8 (en) 2011-10-06
KR20110111307A (ko) 2011-10-10
US20140302071A1 (en) 2014-10-09
AU2010212193B2 (en) 2015-05-14
MX2011008179A (es) 2011-09-09
EP2393830A1 (en) 2011-12-14
HRP20150317T1 (hr) 2015-04-24
AU2010212193A1 (en) 2011-08-18
EP2393830B1 (en) 2015-01-28
CN103784952B (zh) 2016-08-17
JP5746053B2 (ja) 2015-07-08
ES2532759T3 (es) 2015-03-31
EA020792B1 (ru) 2015-01-30
PT2393830E (pt) 2015-04-23
NZ594268A (en) 2013-05-31
SG173523A1 (en) 2011-09-29
EP2393830B8 (en) 2015-03-18
WO2010089554A1 (en) 2010-08-12
CN103784952A (zh) 2014-05-14
EP2891662A1 (en) 2015-07-08
SI2393830T1 (sl) 2015-04-30
EA201171001A1 (ru) 2012-02-28
IL214257A0 (en) 2011-09-27
JP2012516693A (ja) 2012-07-26
JP6215252B2 (ja) 2017-10-18
HK1212358A1 (en) 2016-06-10
CN102307893A (zh) 2012-01-04
DK2393830T3 (en) 2015-04-27
US8753644B2 (en) 2014-06-17
ZA201105436B (en) 2012-09-26

Similar Documents

Publication Publication Date Title
IL214257A (en) Preparation containing polypeptides for use in preventing and treating allergy to herbal dust by tolerating
PL2563135T3 (pl) Kompozycja do kontrolowania chorób roślin i jej zastosowanie
PL2771041T3 (pl) Kompozycje i ich zastosowanie w gojeniu się kości
IL248880B (en) Preparations containing r-g-cysteic acid peptides and their uses for the treatment of eye diseases
IL230120B (en) Preparations containing recombinant iduronate-2-sulfatase and their uses
EP2403472A4 (en) AMPHOLYTIC TERPOLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS
IL218169A (en) Quinazoline compounds and their pharmaceutical compositions containing them for use in therapy
IL232073A0 (en) Recombinant human naglu protein and its uses
GB2501611B (en) Alpha-2-macroglobulin compositions and therapeutic uses
EP2334312A4 (en) COMPOSITIONS COMPRISING PLANT EXTRACTS AND THEIR USE FOR TREATING INFLAMMATION
ZA201400878B (en) Plant disease control composition and its use
ZA201106429B (en) Improvements in and relating to posts
ZA201209705B (en) Ipmrovements in or relating to ophthalmology
PT2403336E (pt) Composições de tratamento de plantas e métodos para a sua utilização
ZA201209701B (en) Improvements in or relating to ophthalmology
ZA201207244B (en) Plant disease control composition and its use
PL2563140T3 (pl) Kompozycja do kontrolowania chorób roślin i jej zastosowanie
GB201108383D0 (en) Improvements in and relating to pharmaceutical compositions
EP2268801A4 (en) COMPOSITIONS AND METHODS RELATED TO A HUMAN BOCAVIRUS
IL218726A (en) Pharmaceuticals for the treatment of Down syndrome
IL209220A0 (en) Plant extract and its therapeutic use
GB201011094D0 (en) Improvements in or relating to ophthalmology
IL221809A (en) Herbal preparation for the prevention and / or treatment of anxiety and related conditions
GB201009275D0 (en) Improvements in or relating to compositions
GB0917454D0 (en) Improvements in and relating to thermostats

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees